Bevufenogene nofeparvovec

诺哌贝基

Report date: 2024/09/10 15:11:20

Base Information

Drug NameBevufenogene nofeparvovec
Drug Alias NameAAVHSC vectorsHMI-102AAVHSC15-PAH
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector > AAVHSC15 vector
Mechanisms of ActionGene transference
TargetsNot applicable
Therapy Area/IndicationsPhenylketonurias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHomology Medicines Security Corporation
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesQ32 Bio Inc
Active IndicationsN/A
Inactive IndicationsPhenylketonurias

Other Information

ATC CodeN/A
Related LinksN/A